Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnitude of rater differences in assessment scales for schizophrenia.
Suzuki T, Takeuchi H, Nakajima S, Nomura K, Uchida H, Yagi G, Watanabe K, Kashima H. Suzuki T, et al. Among authors: nomura k. J Clin Psychopharmacol. 2010 Oct;30(5):607-11. doi: 10.1097/JCP.0b013e3181f0bae1. J Clin Psychopharmacol. 2010. PMID: 20814326 Clinical Trial.
Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia.
Suzuki T, Uchida H, Tanaka KF, Tomita M, Tsunoda K, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H. Suzuki T, et al. Among authors: nomura k. Int Clin Psychopharmacol. 2003 Nov;18(6):323-9. doi: 10.1097/00004850-200311000-00003. Int Clin Psychopharmacol. 2003. PMID: 14571152
How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
Suzuki T, Uchida H, Watanabe K, Nomura K, Takeuchi H, Tomita M, Tsunoda K, Nio S, Den R, Manki H, Tanabe A, Yagi G, Kashima H. Suzuki T, et al. Among authors: nomura k. Psychopharmacology (Berl). 2007 Dec;195(2):285-95. doi: 10.1007/s00213-007-0872-2. Epub 2007 Aug 14. Psychopharmacology (Berl). 2007. PMID: 17701027 Clinical Trial.
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone.
Suzuki T, Uchida H, Watanabe K, Nakajima S, Nomura K, Takeuchi H, Tanabe A, Yagi G, Kashima H. Suzuki T, et al. Among authors: nomura k. Hum Psychopharmacol. 2008 Aug;23(6):455-63. doi: 10.1002/hup.959. Hum Psychopharmacol. 2008. PMID: 18537222 Clinical Trial.
A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.
Takeuchi H, Suzuki T, Uchida H, Nakajima S, Nomura K, Kikuchi T, Manki H, Watanabe K, Kashima H. Takeuchi H, et al. Among authors: nomura k. J Clin Psychopharmacol. 2008 Oct;28(5):540-3. doi: 10.1097/JCP.0b013e3181842586. J Clin Psychopharmacol. 2008. PMID: 18794650 Clinical Trial.
2,466 results